130nm OTP Non Volatile Memory for Standard CMOS Logic Process
Five intellectual property trends to watch in 2013
Mike McLean, UBM TechInsights
EETimes (1/11/2013 12:01 AM EST)
Intellectual property and patents became headline news in 2012 as lawsuits, sales and competitive gamesmanship resulted in an increasing number of firms actively employing intellectual assets as viable tools for building their businesses. The likes of Google, Samsung, Kodak, Apple and Marvell were linked to millions (and billions) of dollars in litigation.
We expect ongoing growth in the number of companies seeking to enhance an IP position and leverage their rights aggressively. Our research shows an increasing variety of competitors seeking to capitalize on product, design and intellectual innovation.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
- 4G Intellectual Property Royalties Set to Quadruple over the Next Five Years
- ANADIGICS Expands Intellectual Property Portfolio; ANADIGICS Granted Five New Patents for Innovations in RFIC Design
- BrainChip's Latest US Patent Award Extends Intellectual Property Strength and its Leadership in Edge Learning
- GlobalFoundries Files Lawsuit Against IBM to Protect its Intellectual Property and Trade Secrets
- EU Chips Act: Key Intellectual Property Considerations
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design